Prognostic value of GST-π expression in diffuse large B-cell lymphomas
✍ Scribed by Ribrag, V; Koscielny, S; Carpiuc, I; Cebotaru, C; Vande Walle, H; Talbot, M; Fenaux, P; Bosq, J
- Book ID
- 110055472
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 320 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Diffuse large B‐cell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A
## Abstract ## Objective Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, with a correlation between RA disease severity and lymphoma risk, most pronounced for diffuse large B cell lymphomas (DLBCLs), which also constitute the majority of RA‐associated lymphoma